evidence-based medicine & psychiatry

Advertisement



Attention Valued Visitor: A Drug Reference Page for FDA Approved General Anesthetics is now available!
Shawn Thomas (Shawn@neurotransmitter.net) is working to summarize the mechanisms of action of every drug approved by the FDA for a brain- related condition. In addition, new pages with more automated content will soon replace some of the older pages on the web site. If you have suggestions about content that you would like to see, e-mail Shawn@neurotransmitter.net if you have anything at all to share.


 

Google
 
Web www.neurotransmitter.net

(Updated 3/9/04)

David L Sackett, William M C Rosenberg, J A Muir Gray, R Brian Haynes, W Scott Richardson
Evidence based medicine: what it is and what it isn't
BMJ 1996;312:71-72
"Evidence based medicine is the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. The practice of evidence based medicine means integrating individual clinical expertise with the best available external clinical evidence from systematic research. By individual clinical expertise we mean the proficiency and judgment that individual clinicians acquire through clinical experience and clinical practice. Increased expertise is reflected in many ways, but especially in more effective and efficient diagnosis and in the more thoughtful identification and compassionate use of individual patients' predicaments, rights, and preferences in making clinical decisions about their care. By best available external clinical evidence we mean clinically relevant research, often from the basic sciences of medicine, but especially from patient centred clinical research into the accuracy and precision of diagnostic tests (including the clinical examination), the power of prognostic markers, and the efficacy and safety of therapeutic, rehabilitative, and preventive regimens. External clinical evidence both invalidates previously accepted diagnostic tests and treatments and replaces them with new ones that are more powerful, more accurate, more efficacious, and safer.

Good doctors use both individual clinical expertise and the best available external evidence, and neither alone is enough. Without clinical expertise, practice risks becoming tyrannised by evidence, for even excellent external evidence may be inapplicable to or inappropriate for an individual patient. Without current best evidence, practice risks becoming rapidly out of date, to the detriment of patients." [Full Text]

R Brian Haynes
What kind of evidence is it that Evidence-Based Medicine advocates want health care providers and consumers to pay attention to?
BMC Health Services Research 2002, 2:3
"BACKGROUND: In 1992, Evidence-Based Medicine advocates proclaimed a "new paradigm", in which evidence from health care research is the best basis for decisions for individual patients and health systems. Hailed in New York Times Magazine in 2001 as one of the most influential ideas of the year, this approach was initially and provocatively pitted against the traditional teaching of medicine, in which the key elements of knowing for clinical purposes are understanding of basic pathophysiologic mechanisms of disease coupled with clinical experience. This paper reviews the origins, aspirations, philosophical limitations, and practical challenges of evidence-based medicine. DISCUSSION: EBM has long since evolved beyond its initial (mis)conception, that EBM might replace traditional medicine. EBM is now attempting to augment rather than replace individual clinical experience and understanding of basic disease mechanisms. EBM must continue to evolve, however, to address a number of issues including scientific underpinnings, moral stance and consequences, and practical matters of dissemination and application. For example, accelerating the transfer of research findings into clinical practice is often based on incomplete evidence from selected groups of people, who experience a marginal benefit from an expensive technology, raising issues of the generalizability of the findings, and increasing problems with how many and who can afford the new innovations in care. SUMMARY: Advocates of evidence-based medicine want clinicians and consumers to pay attention to the best findings from health care research that are both valid and ready for clinical application. Much remains to be done to reach this goal." [Full Text]

R Brian Haynes, P J Devereaux, Gordon H Guyatt
Physicians' and patients' choices in evidence based practice
BMJ 2002;324:1350, doi:10.1136/bmj.324.7350.1350
"The notion that decisions may vary from circumstance to circumstance, and from patient to patient with the same circumstances, has received increasing attention. But achieving the right balance among the factors that can affect a decision is not necessarily easy. Indeed, providing evidence to patients in a way that allows them to make an informed choice is challenging and in many cases beyond our current knowledge of doctor-patient communicationvery much a problem awaiting the generation of new evidence.

The term evidence based medicine was developed to encourage practitioners and patients to pay due respectno more, no lessto current best evidence in making decisions. An alternative term that some may find more appealing is research enhanced health care. Whichever term is applied, one can be confident in making better use of research evidence in clinical practice, especially if the wishes of the patient are taken into account." [Full Text]

S E Straus, D L Sackett
Getting research findings into practice: Using research findings in clinical practice
BMJ 1998;317:339-342
"Applying the results of critical appraisals involves the essential second element of evidence based medicine: integrating the evidence with clinical expertise and knowledge of the unique features of patients and their situations, rights, and expectations. Only after these things have been considered can we then decide whether and how to incorporate the evidence into the care of a particular patient." [Full Text]

Brian Haynes, Andrew Haines
Getting research findings into practice: Barriers and bridges to evidence based clinical practice
BMJ 1998;317:273-276
"Clinicians and healthcare planners who want to improve the quality and efficiency of healthcare services will find help in research evidence. This evidence is increasingly accessible through information services that combine high quality evidence with information technology. However, there are several barriers to the successful application of research evidence to health care. We discuss both the prospects for harnessing evidence to improve health care and the problems that readersclinicians, planners, and patientswill need to overcome to enjoy the benefits of research." [Full Text]

LAWRIE, STEPHEN M., SCOTT, ALLAN I.F., SHARPE, MICHAEL C.
Implementing evidence-based psychiatry: whose responsibility?
Br J Psychiatry 2001 178: 195-196
"Evidence-based medicine is fine in principle, but needs to demonstrate tangible benefits to clinicians and their patients in practice. The main obstacles to its implementation are: (a) identifying information needs; (b) delivering reliable and clinically useful information to the ward/clinic; and (c) ensuring the information is regularly updated. How can this be achieved in psychiatry?" [Full Text]

Palmer, Claire, Lelliott, Paul
Encouraging the implementation of clinical standards into practice
Psychiatr Bull 2000 24: 90-93
"Implementing clinical standards is not a linear process of ‘information provision=implementation’. It is not even as simple as ‘information+training+resources=implementation’. It is a complex and ‘messy’ process. An individual implementation method, or even combination of methods, may work for one individual or group but not another. It appears from the research in this area that the best implementation strategy is one which uses a wide range of different approaches in the hope that it will provide something which works for the maximum number of people." [Full Text]

Ted J Kaptchuk
Effect of interpretive bias on research evidence
BMJ 2003;326:1453-1455, doi:10.1136/bmj.326.7404.1453
"Doctors are being encouraged to improve their critical appraisal skills to make better use of medical research. But when using these skills, it is important to remember that interpretation of data is inevitably subjective and can itself result in bias." [Full Text]

A C Freeman, K Sweeney
Why general practitioners do not implement evidence: qualitative study
BMJ 2001;323:1100, doi:10.1136/bmj.323.7321.1100
"This study suggests that the general practitioner acts as a conduit in consultations in which clinical evidence is one commodity. For some doctors the evidence had clarified practice, focused clinical effort, and sometimes radically altered practice. But a stronger theme from our data is that doctors are shaping the square peg of the evidence to fit the round hole of the patient's life. The nature of the conduit is determined partly by the doctors' previous experiences and feelings. These feelings can be about the patient, the evidence itself, or where the evidence has come from (the hospital setting). The conduit is also influenced by the doctor-patient relationship. The precise words used by practitioners in their role as conduit can affect how evidence is implemented. In some settings, logistical problems will diminish the effectiveness of the conduit." [Full Text]

Ian Kerridge, Michael Lowe, David Henry
Personal paper: Ethics and evidence based medicine
BMJ 1998;316:1151-1153
"However, the presence of reliable evidence does not ensure that better decisions will be made. Claims that evidence based medicine offers an improved method of decision making are difficult to evaluate because current practice is so poorly defined. Medical decision making draws upon a broad spectrum of knowledgeincluding scientific evidence, personal experience, personal biases and values, economic and political considerations, and philosophical principles (such as concern for justice). It is not always clear how practitioners integrate these factors into a final decision, but it seems unlikely that medicine can ever be entirely free of value judgments." [Full Text]

Goldman, Howard H., Ganju, Vijay, Drake, Robert E., Gorman, Paul, Hogan, Michael, Hyde, Pamela S., Morgan, Oscar
Policy Implications for Implementing Evidence-Based Practices
Psychiatric Services 2001 52: 1591-1597
"The authors describe the policy and administrative-practice implications of implementing evidence-based services, particularly in public-sector settings. They review the observations of the contributors to the evidence-based practices series published throughout 2001 in Psychiatric Services. Quality and accountability have become the watchwords of health and mental health services; evidence-based practices are a means to both ends. If the objective of accountable, high-quality services is to be achieved by implementing evidence-based practices, the right incentives must be put in place, and systemic barriers must be overcome. The authors use the framework from the U.S. Surgeon General's 1999 report on mental health to describe eight courses of action for addressing the gap between science and practice: continue to build the science base; overcome stigma; improve public awareness of effective treatments; ensure the supply of mental health services and providers; ensure delivery of state-of-the-art treatments; tailor treatment to age, sex, race, and culture; facilitate entry into treatment; and reduce financial barriers to treatment." [Full Text]

Schoenwald, Sonja K., Hoagwood, Kimberly
Effectiveness, Transportability, and Dissemination of Interventions: What Matters When?
Psychiatric Services 2001 52: 1190-1197
"The authors identify and define key aspects of the progression from research on the efficacy of a new intervention to its dissemination. They highlight the role of transportability questions that arise in that progression and illustrate key conceptual and design features that differentiate efficacy, effectiveness, and dissemination research. An ongoing study of the transportability of multisystemic therapy is used to illustrate independent and interdependent aspects of effectiveness, transportability, and dissemination studies. Variables relevant to the progression from treatment efficacy to dissemination include features of the intervention itself as well as variables pertaining to the practitioner, client, model of service delivery, organization, and service system. The authors provide examples of how some of these variables are relevant to the transportability of different types of interventions. They also discuss sample research questions, study designs, and challenges to be anticipated in the arena of transportability research." [Full Text]

GILBODY, SIMON M., HOUSE, ALLAN O., SHELDON, TREVOR A.
Outcomes research in mental health: Systematic review
Br J Psychiatry 2002 181: 8-16
"BACKGROUND: Outcomes research involves the secondary analysis of data collected routinely by clinical services, in order to judge the effectiveness of interventions and policy initiatives. It permits the study of large databases of patients who are representative of 'real world' practice. However, there are potential problems with this observational design. AIMS: To establish the strengths and limitations of outcomes research when applied in mental health. METHOD: A systematic review was made of the application of outcomes research in mental health services research. RESULTS: Nine examples of outcomes research in mental health services were found. Those that used insurance claims data have information on large numbers of patients but use surrogate outcomes that are of questionable value to clinicians and patients. Problems arise when attempting to adjust for important confounding variables using routinely collected claims data, making results difficult to interpret. CONCLUSIONS: Outcomes research is unlikely to be a quick or cheap means of establishing evidence for the effectiveness of mental health practice and policy." [Full Text]

MARGISON, FRANK R., McGRATH, GRAEME, BARKHAM, MICHAEL, CLARK, JOHN MELLOR, AUDIN, KERRY, CONNELL, JANICE, EVANS, CHRIS
Measurement and psychotherapy: Evidence-based practice and practice-based evidence
Br J Psychiatry 2000 177: 123-130
"BACKGROUND: Measurement is the foundation of evidence-based practice. Advances in measurement procedures should extend to psychotherapy practice. AIMS: To review the developments in measurement relevant to psychotherapy. METHOD: Domains reviewed are: (a) interventions; (b) case formulation; (c) treatment integrity; (d) performance (including adherence, competence and skillfulness); (e) treatment definitions; (f) therapeutic alliance; and (g) routine outcome measurement. RESULTS: Modern methods of measurement can support 'evidence-based practice' for psychological treatments. They also support 'practice-based evidence', a complementary paradigm to improve clinical effectiveness in routine practice via the infrastructure of Practice Research Networks (PRNs). CONCLUSIONS: Advances in measurement derived from psychotherapy research support a model of professional self-management (practice-based evidence) which is widely applicable in psychiatry and medicine." [Full Text]

Roberts, Glenn A.
Narrative and severe mental illness: what place do stories have in an evidence-based world?
Adv Psychiatr Treat 2000 6: 432-441
"Science and narrative, the quantitative and qualitative, are not competitors but represent a complementary duality, as intimately connected as the two sides of the cerebral cortex. Narrative preserves individuality, distinctiveness and context, whereas quantitative methods and evidence-based guidelines offer a solid foundation for what is reliably and generally correct. Palmer (2000) has argued that it is clinicians who need to bridge the gap, if they are to be able both to appraise evidence and appreciate the meaningful experience of their patients: "It may be uncomfortable to ride the twin horses of rigour and richness, of general scepticism and particular enthusiasm, but the clinician has to try to do so".

Narrative is endemic to medicine, but has been excluded in the rise of EBM. It remains to be seen whether narrative's ecumenicalism will be rebuffed or reconciled with EBM's fundamentalism, but there are signs of convergence. A recent issue of the Journal of Evidence-Based Health Care (October, 1999) began by declaring that "This issue of Bandolier is mostly about updating stories from previous months and years", and went on to state that "reviews are also beginning to concentrate more on outcomes that are important to patients and practitioners, rather than just on outcomes that are measurable".

There is an emerging image of the mature and experienced clinician of the future, who will have the capacity to integrate narrative- and evidence-based perspectives, quantitative and qualitative methods, and have a balanced awareness of the contributions and limitations of both as a sound basis for clinical judgements. However, if this is to be more than a heroic ideal, our initial training and continuing professional development will need to encourage the simultaneous development of both the art and science of our subject, reconciling probabilistic P-values with personalistic ‘P-values’." [Full Text]

Roberts, Glenn, Wolfson, Paul
The rediscovery of recovery: open to all
Adv Psychiatr Treat 2004 10: 37-48
"‘Recovery’ is usually taken as broadly equivalent to ‘getting back to normal’ or ‘cure’, and by these standards few people with severe mental illness recover. At the heart of the growing interest in recovery is a radical redefinition of what recovery means to those with severe mental health problems. Redefinition of recovery as a process of personal discovery, of how to live (and to live well) with enduring symptoms and vulnerabilities opens the possibility of recovery to all. The ‘recovery movement’ argues that this reconceptualisation is personally empowering, raising realistic hope for a better life alongside whatever remains of illness and vulnerability. This paper explores the background and defining features of the international recovery movement, its influence and impact on contemporary psychiatric practice, and steps towards developing recovery-based practice and services." [Abstract]

Frese, Frederick J., III, Stanley, Jonathan, Kress, Ken, Vogel-Scibilia, Suzanne
Integrating Evidence-Based Practices and the Recovery Model
Psychiatric Services 2001 52: 1462-1468
"Consumer advocacy has emerged as an important factor in mental health policy during the past few decades. Winning consumer support for evidence-based practices requires recognition that consumers' desires and needs for various types of treatments and services differ significantly. The authors suggest that the degree of support for evidence-based practices by consumer advocates depends largely on the degree of disability of the persons for whom they are advocating. Advocates such as members of the National Alliance for the Mentally Ill, who focus on the needs of the most seriously disabled consumers, are most likely to be highly supportive of research that is grounded in evidence-based practices. On the other hand, advocates who focus more on the needs of consumers who are further along their road to recovery are more likely to be attracted to the recovery model. Garnering the support of this latter group entails ensuring that consumers, as they recover, are given increasing autonomy and greater input about the types of treatments and services they receive. The authors suggest ways to integrate evidence-based practices with the recovery model and then suggest a hybrid theory that maximizes the virtues and minimizes the weaknesses of each model." [Full Text]

Fisher, Daniel B., Ahern, Laurie
Evidence-Based Practices and Recovery
Psychiatric Services 2002 53: 632-a-633 [Full Text]


MARKS, ISAAC M.
The maturing of therapy: Some brief psychotherapies help anxiety/depressive disorders but mechanisms of action are unclear
Br J Psychiatry 2002 180: 200-204
"BACKGROUND: Psychiatric therapy needs assessment regarding its maturation as a therapeutic science. AIMS: Judgement of whether such a science is emerging. METHOD: Four criteria are used: efficacy; identification of responsible treatment components; knowledge of their mechanisms of action; and elucidation of why they act only in some sufferers. RESULTS: Brief behavioural, interpersonal, cognitive, problem-solving and other psychotherapies have a mature ability to improve anxiety and depressive disorders reliably and enduringly, often only with instruction from a manual or a computer. Therapy's cost-effectiveness and acceptability deserve more attention. We know little about which treatment components produce improvement, how they do so and why they do not help all sufferers. CONCLUSIONS: Therapy is coming of age regarding efficacy for anxiety and depression, but is only a toddler regarding the scientific principles to explain its effects." [Full Text]

Sensky, Tom
Knowledge management
Adv Psychiatr Treat 2002 8: 387-395
"More generally, the need for personal knowledge management skills underlies the widespread acknowledgement that now, more than ever before, it is impossible for a clinician to acquire sufficient knowledge during training to equip him or her for the duration of a professional career. This is reflected not only in the importance attached to continuing professional development, but also in the change in emphasis during undergraduate medical training from the acquisition of facts to the development of skills needed for lifelong learning." [Full Text]

Stuart Barton
Which clinical studies provide the best evidence?
BMJ 2000;321:255-256, doi:10.1136/bmj.321.7256.255
"The new studies do not justify a major revision of the hierarchy of evidence, but they do support a flexible approach in which randomised controlled trials and observational studies have complementary roles. High quality observational studies may extend evidence over a wider population and are likely to be dominant in the identification of harms and when randomised controlled trials would be unethical or impractical." [Full Text]

Hoagwood, Kimberly, Burns, Barbara J., Kiser, Laurel, Ringeisen, Heather, Schoenwald, Sonja K.
Evidence-Based Practice in Child and Adolescent Mental Health Services
Psychiatric Services 2001 52: 1179-1189
"The authors review the status, strength, and quality of evidence-based practice in child and adolescent mental health services. The definitional criteria that have been applied to the evidence base differ considerably across treatments, and these definitions circumscribe the range, depth, and extensionality of the evidence. The authors describe major dimensions that differentiate evidence-based practices for children from those for adults and summarize the status of the scientific literature on a range of service practices. The readiness of the child and adolescent evidence base for large-scale dissemination should be viewed with healthy skepticism until studies of the fit between empirically based treatments and the context of service delivery have been undertaken. Acceleration of the pace at which evidence-based practices can be more readily disseminated will require new models of development of clinical services that consider the practice setting in which the service is ultimately to be delivered." [Full Text]


Hoagwood, Kimberly
Making the Translation from Research to Its Application: The Je Ne Sais Pas of Evidence-Based Practices
Clin. Psychol. 2002 9: 210-213
"Moving evidence-based treatments into practice settings is an important new direction for the field of children's mental health., but is fraught with many unknowns. This commentary discusses scientific conundrums that surround that transportability of research-based interventions, including issues of definition (e.g., differences among treatments, preventive interventions, services); diagnostic reification and the absence of markers; the value and status of combination treatments (including pharmacologic) for conceptualizing the evidence base; and differences between evidence-based practices and evidence-based treatments. Suggestions are made for a disciplined approach to advancing a yoked research and policy agenda for children's mental health." [Abstract]

GEDDES, JOHN, GOODWIN, GUY
Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials
Br J Psychiatry 2001 178: 191s-194
"BACKGROUND: The increasing use of the methods of evidence-based medicine to keep up-to-date with the research literature highlights the absence of high-quality evidence in many areas in psychiatry. AIMS: To outline current uncertainties in the maintenance treatment of bipolar disorder and to describe some of the decisions involved in designing a large simple trial. METHOD: We describe some of the strategies of evidence-based medicine, and how they can be applied in practice, focusing specifically on the area of bipolar disorder. RESULTS: One of the key clinical uncertainties in the treatment of bipolar disorder is the place of maintenance drug treatments and their relative efficacy. A large-scale study, the Bipolar Affective Disorder: Lithium Anticonvulsant Evaluation (BALANCE) trial, is proposed to compare the effectiveness of lithium, valproate and the combination of lithium and valproate. CONCLUSIONS: Providing reliable answers to key clinical questions in psychiatry will require new approaches to clinical trials. These will need to be far larger than previously appreciated and will therefore need to be collaborative ventures involving front-line clinicians." [Full Text]

Drake, Robert E., Goldman, Howard H., Leff, H. Stephen, Lehman, Anthony F., Dixon, Lisa, Mueser, Kim T., Torrey, William C.
Implementing Evidence-Based Practices in Routine Mental Health Service Settings
Psychiatric Services 2001 52: 179-182
"The authors describe the rationale for implementing evidence-based practices in routine mental health service settings. Evidence-based practices are interventions for which there is scientific evidence consistently showing that they improve client outcomes. Despite extensive evidence and agreement on effective mental health practices for persons with severe mental illness, research shows that routine mental health programs do not provide evidence-based practices to the great majority of their clients with these illnesses. The authors define the differences between evidence-based practices and related concepts, such as guidelines and algorithms. They discuss common concerns about the use of evidence-based practices, such as whether ethical values have a role in shaping such practices and how to deal with clinical situations for which no scientific evidence exists." [Full Text]

Torrey, William C., Drake, Robert E., Dixon, Lisa, Burns, Barbara J., Flynn, Laurie, Rush, A. John, Clark, Robin E., Klatzker, Dale
Implementing Evidence-Based Practices for Persons With Severe Mental Illnesses
Psychiatric Services 2001 52: 45-50
"Extensive empirical research, summarized in several reviews and codified in practice guidelines, recommendations, and algorithms, demonstrates that several pharmacological and psychosocial interventions are effective in improving the lives of persons with severe mental illnesses. Yet the practices validated by research are not widely offered in routine mental health practice settings. As part of an effort to promote the implementation of evidence-based practice, the authors summarize perspectives on how best to change and sustain effective practice from the research literature and from the experiences of administrators, clinicians, family advocates, and services researchers. They describe an implementation plan for evidence-based practices based on the use of toolkits to promote the consistent delivery of such practices. The toolkits will include integrated written material, Web-based resources, training experiences, and consultation opportunities. Special materials will address the concerns of mental health authorities (funders), administrators of provider organizations, clinicians, and consumers and their families." [Full Text]

Cruz, Mario, Pincus, Harold Alan
Research on the Influence That Communication in Psychiatric Encounters Has on Treatment
Psychiatric Services 2002 53: 1253-1265
"OBJECTIVE: The purpose of this article is to inform mental health professionals about the empirical literature on medical and psychiatric encounters and the influence of communicative behaviors on specific encounter outputs and treatment outcomes. METHODS: A comprehensive review of the health communications literature from 1950 to 2001, using MEDLINE and PsycINFO, was conducted to identify relevant articles on the communication skills of psychiatrists and other physicians. These searches were augmented by personal correspondence with experts on changes in practice patterns in psychiatry and on medical and psychiatric communications research. A review of references within each article and information from the experts identified other relevant articles. Selection was then narrowed to include reports of studies that used structured written instruments that captured relevant physician and patient perceptions of the physician-patient relationship, content analysis of audio- or videotapes of communication in medical or psychiatric encounters, or interaction analysis systems used to categorize audio- or videotaped communicative behaviors in medical or psychiatric encounters. RESULTS AND CONCLUSIONS: Twenty-five articles in medicine and 34 articles in psychiatry were selected. Medical communication researchers have observed associations between physicians' communicative skills and patients' satisfaction, patients' adherence to treatment recommendations, treatment outputs, and patients' willingness to file malpractice claims. The research has also shown that primary care physicians can be more responsive to patients' concerns without lengthening visits. In psychiatry, the literature can be organized into four discrete categories of research: negotiated treatment and the customer approach, therapeutic alliance, Gottschalk-Gleser content analysis of patients' speech, and content analysis of psychiatric interviews." [Full Text]

Mike Shooter
The patient's perspective on medicines in mental illness
BMJ 2003;327:824-826, doi:10.1136/bmj.327.7419.824
"Worldwide 40 antipsychotic preparations are available and twice as many antidepressants. As a patient with a recurrent depressive disorder myself it would be comforting to think that choice of treatment is based on a concordance between the patient's wishes and the doctor's advice. In reality it will reflect the many factors that affect their relationship—medical attitudes; the way information is presented; the capacity of patients to understand this information and to relate it to their condition; health service, social, and commercial pressures. Not surprisingly, Cochrane reviews of interventions to improve "adherence" show findings that are inconsistent or complex. Adherence can only be improved by mutual respect." [Full Text]

Eysenbach G, Jadad AR.
Evidence-based patient choice and consumer health informatics in the Internet age.
J Med Internet Res. 2001 Apr-Jun;3(2):E19.
"In this paper we explore current access to and barriers to health information for consumers. We discuss how computers and other developments in information technology are ushering in the era of consumer health informatics, and the potential that lies ahead. It is clear that we witness a period in which the public will have unprecedented ability to access information and to participate actively in evidence-based health care. We propose that consumer health informatics be regarded as a whole new academic discipline, one that should be devoted to the exploration of the new possibilities that informatics is creating for consumers in relation to health and health care issues." [Full Text]

Gunther Eysenbach
Recent advances: Consumer health informatics
BMJ 2000;320:1713-1716, doi:10.1136/bmj.320.7251.1713
"Medical informatics has expanded rapidly over the past couple of years. After decades of development of information systems designed primarily for physicians and other healthcare managers and professionals, there is an increasing interest in reaching consumers and patients directly through computers and telecommunications systems. Consumer health informatics is the branch of medical informatics that analyses consumers' needs for information; studies and implements methods of making information accessible to consumers; and models and integrates consumers' preferences into medical information systems. Consumer informatics stands at the crossroads of other disciplines, such as nursing informatics, public health, health promotion, health education, library science, and communication science, and is perhaps the most challenging and rapidly expanding field in medical informatics; it is paving the way for health care in the information age." [Full Text]

Gunther Eysenbach, Eun Ryoung Sa, Thomas L Diepgen
Shopping around the internet today and tomorrow: towards the millennium of cybermedicine
BMJ 1999;319:1294
"The fact that patients have access to the same databases as clinicians leads to increased consumer knowledge, which is pushing clinicians to higher quality standards and evidence based medicine." [Full Text]

Beveridge, Allan
Time to abandon the subjective--objective divide?
Psychiatr Bull 2002 26: 101-103
"In the mental state examination, a standard method of describing the clinical encounter is to contrast the patient's supposedly ‘subjective’ account with the doctor's ‘objective’ description. In this model, the doctor is granted a privileged position: the clinician's perspective is taken to be superior to that of the patient. The doctor's objective approach is considered neutral, scientific and representing the truth of the matter. In contrast, the patient's subjective report is regarded as unreliable, distorted and potentially false. The lowly status of the subjective perspective is further emphasised by the frequent use of the accompanying prefix, merely.

On reflection, this dichotomy is an extraordinary one. It is held that the doctor is an authority on the patient's inner experiences. The doctor knows more about how the patient is thinking and feeling than the patient him-/herself. This belief ignores the preconceptions and prejudices that the clinician brings to the interview. It ignores the impact that the interview has on how the doctor perceives the patient, and how the patient responds. In the physical sciences, it has long been recognised that the observer has an influence on what is being observed." [Full Text]

Saunders, John
The practice of clinical medicine as an art and as a science
Medical Humanities 2000 26: 18-22
"The practice of modern medicine is the application of science, the ideal of which has the objective of value-neutral truth. The reality is different: practice varies widely between and within national medical communities. Neither evidence from randomised controlled trials nor observational methods can dictate action in particular circumstances. Their conclusions are applied by value judgments that may be impossible to specify in "focal particulars". Herein lies the art which is integral to the practice of medicine as applied science." [Full Text]

Summerfield, D.
Culture-specific psychiatric illness?
Br J Psychiatry 2001 179: 460-
"All of psychiatry is culture-bounded, not just a few syndromes in the DSM or ICD: even presentations by patients with organic disorders are embedded in particular ‘lifeworlds’ and local forms of knowledge. Western psychiatry is but one among many ethnopsychiatries." [Abstract]

EISENBERG, LEON
Is psychiatry more mindful or brainier than it was a decade ago?
Br J Psychiatry 2000 176: 1-5
"Nature and nurture stand in reciprocity, not opposition. Children inherit - along with their parents' genes - their parents, their peers and the places they inhabit. Neighbourhood and neighbours matter, as do parents and siblings. The distribution of health and disease in human populations reflects environmental factors (where people live, what they eat, the work they do, the air and water they consume, their degree of connection with others, and the status they occupy in the social order) as well as what they inherit, namely their relative vulnerabilities and resistances to environmental pathogens.

Biomedical knowledge is essential for providing sound medical care but it is not sufficient; the doctor's transactions with the patient must also be informed by psychosocial understanding. Neither mindlessness nor brainlessness can be tolerated in medicine. The unique role of psychiatry will be its contribution to a new paradigm: brain/mindfulness, integrating neurobiology with behaviour in its social context. That is the intellectual challenge ahead." [Full Text]

HOLMES, JEREMY
Fitting the biopsychosocial jigsaw together
Br J Psychiatry 2000 177: 93-94 [Full Text]

Patrick Bracken, Philip Thomas
Postpsychiatry: a new direction for mental health
BMJ 2001;322:724-727, doi:10.1136/bmj.322.7288.724 [Full Text]
[Be sure to read the rapid responses.]

Duncan Double
The limits of psychiatry
BMJ 2002;324:900-904, doi:10.1136/bmj.324.7342.900
"Much of the expansion of psychiatry in the past few decades has been based on a biomedical model that encourages drug treatment to be seen as a panacea for multiple problems. Psychiatrist Duncan Double is sceptical of this approach and suggests that psychiatry should temper and complement a biological view with psychological and social understanding, thus recognising the uncertainties of clinical practice." [Full Text]

COOPER, BRIAN
Evidence-based mental health policy: a critical appraisal
Br J Psychiatry 2003 183: 105-113
"BACKGROUND: Arguments for and against evidence-based psychiatry have mostly centred on its value for clinical practice and teaching. Now, however, use of the same paradigm in evaluating health care has generated new problems. AIMS: To outline the development of evidence-based health care; to summarise the main critiques of this approach; to review the evidence now being employed to evaluate mental health care; and to consider how the evidence base might be improved. METHOD: The following sources were monitored: publications on evidence-based psychiatry and health care since 1990; reports of randomised trials and meta-analytic reviews to the end of 2002; and official British publications on mental health policy. RESULTS: Although evidence-based health care is now being promulgated as a rational basis for mental health planning in Britain, its contributions to service evaluation have been distinctly modest. Only 10% of clinical trials and meta-analyses have been focused on effectiveness of services, and many reviews proved inconclusive. CONCLUSIONS: The current evidence-based approach is overly reliant on meta-analytic reviews, and is more applicable to specific treatments than to the care agencies that control their delivery. A much broader evidence base is called for, extending to studies in primary health care and the evaluation of preventive techniques." [Abstract]

Healy, David
Evidence biased psychiatry?
Psychiatr Bull 2001 25: 290-291
"The majority of recent psychotropic drug trials are business rather than scientific exercises, constructed for the purposes of achieving regulatory approval and thereafter market penetration. In the case of regulatory applications for the newer antipsychotics, adopting the null hypothesis for the data leaves fair-minded observers unable to maintain the position that these drugs are without effect. Some recent studies have included comparator arms, using haloperidol in particular. But none of these studies have led to a regulatory labelling of the newer agents as superior to or preferable to haloperidol. In the absence of regulatory indications that the null hypothesis has not been shown to hold when new and older agents are compared, it is difficult to see how the makers of guidelines can make many statements comparing agents. It also becomes possible to see why those who might frame guidelines leave themselves open to a legal challenge from pharmaceutical companies, as has happened in other areas of medicine." [Full Text]

->Back to Home<-



Recent Evidence-Based Medicine & Psychiatry Research

1) Bailey CR, Neumeister A
Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology.
Neurosci Lett. 2011 Jul 20;
[PubMed Citation] [Order full text from Infotrieve]


2) Davies P, Wye L, Horrocks S, Salisbury C, Sharp D
Developing quality indicators for community services: the case of district nursing.
Qual Prim Care. 2011;19(3):155-66.
[PubMed Citation] [Order full text from Infotrieve]


3) Gray KM, Carpenter MJ, Lewis AL, Klintworth EM, Upadhyaya HP
Varenicline versus Bupropion XL for Smoking Cessation in Older Adolescents: A Randomized, Double-Blind Pilot Trial.
Nicotine Tob Res. 2011 Jul 20;
INTRODUCTION: Despite tremendous potential public health impact, little work has focused on development of evidence-based smoking cessation treatments for adolescents, including pharmacotherapies. No prior studies have explored the feasibility and safety of varenicline and bupropion XL, 2 potentially promising pharmacotherapies, as smoking cessation treatments in adolescents. METHODS: Treatment-seeking older adolescent smokers (ages 15-20) were randomized (double-blind) to varenicline (n = 15) or bupropion XL (n = 14), with 1-week titration and active treatment for 7 weeks. Structured safety, tolerability, and efficacy assessments (cotinine-confirmed 7-day point prevalence abstinence) were conducted weekly. RESULTS: There were no serious adverse events. Two participants discontinued bupropion XL due to adverse effects, and none discontinued varenicline. Over the course of treatment, participants receiving varenicline reduced from 14.1 ± 6.3 (mean ± SD) to 0.9 ± 2.1 cigarettes/day (CPD, 4 achieved abstinence), while those receiving bupropion XL reduced from 15.8 ± 4.4 to 3.1 ± 4.0 CPD (2 achieved abstinence). Conclusions: These preliminary results support the feasibility and safety of conducting adequately powered, placebo-controlled efficacy studies of varenicline and bupropion XL for adolescent smoking cessation. [PubMed Citation] [Order full text from Infotrieve]


4) Mrazek DA, Lerman C
Facilitating clinical implementation of pharmacogenomics.
JAMA. 2011 Jul 20;306(3):304-5.
[PubMed Citation] [Order full text from Infotrieve]


5) Perepletchikova F
On the Topic of Treatment Integrity.
Clin Psychol (New York). 2011 Jun;18(2):148-153.
Treatment integrity, also known as treatment fidelity, is integral for empirical testing of intervention efficacy as it allows for unambiguous interpretations of the obtained results. Assuring treatment integrity is also important for dissemination of evidence-based practices and quality improvement of services. However, in the examination of the relationship between treatment integrity and treatment outcome it is important to consider that treatment integrity may be a proxy variable for other variables impacting therapeutic change (e.g., characteristics of intervention, clients, setting, and therapist). Considerations on examining the association between integrity and outcome are discussed. Further, recommendations on the level to which treatment integrity needs to be addressed in psychotherapy research and clinical practice are provided. [PubMed Citation] [Order full text from Infotrieve]


6) Weiss SM, Jones DL, Lopez M, Villar-Loubet O, Chitalu N
The many faces of translational research: a tale of two studies.
Transl Behav Med. 2011 Jun;1(2):327-330.
Translational research can take many forms: bench to bedside, across cultural groups, across geographical boundaries, among others. This case study will share how we addressed all three "translational" issues using two evidence-based studies (USA, Zambia) to illustrate these "roads less traveled." Our implementation and dissemination efforts were anchored by the "train the trainer" strategy, and the Glasgow RE-AIM model provided programmatic guideposts and direction. Keeping all stakeholders (scientific, community, political) involved in the implementation and dissemination process was an essential, perhaps determining factor in the success of the translation process. [PubMed Citation] [Order full text from Infotrieve]


7) Bhugra D, Easter A, Mallaris Y, Gupta S
Clinical decision making in psychiatry by psychiatrists.
Acta Psychiatr Scand. 2011 Jul 8;
Bhugra D, Easter A, Mallaris Y, Gupta S. Clinical decision making in psychiatry by psychiatrists. Objective:? To derive an in-depth understanding of the decision-making process in psychiatry and to explore similarities and differences in psychiatrists' decision-making process and the factors that may influence psychiatrists' decisions. Method:? A total of 31 psychiatrists were interviewed on their approaches to decision making in psychiatric practice, using a semistructured interview guide. Framework analysis was undertaken to derive a qualitative understanding of decision making in psychiatry. Results:? The analysis generated seven main themes, which collectively influenced the decision-making process in psychiatry: information gathering, training in psychiatry, intuition and experience, evidence-based practice, cognitive reasoning, uncontrollable factors and multidisciplinary team influences. Conclusion:? No single approach to decision making emerged from the analysis. Approaches to decision making were influenced by the level of clinical experience and external pressures, such as time and treatment availability. Findings were consistent with dual-processing theory of decision making. [PubMed Citation] [Order full text from Infotrieve]


8) Batelaan NM, Van Balkom AJ, Stein DJ
Evidence-based pharmacotherapy of panic disorder: an update.
Int J Neuropsychopharmacol. 2011 Jun 9;:1-13.
The evidence-based pharmacotherapy of panic disorder continues to evolve. This paper reviews data on first-line pharmacotherapy, evidence for maintenance treatment, and management options for treatment-refractory patients. A Medline search of research on pharmacotherapy was undertaken, and a previous systematic review on the evidence-based pharmacotherapy of panic disorder was updated. Selective serotonin reuptake inhibitors remain a first-line pharmacotherapy of panic disorder, with the serotonin noradrenaline reuptake inhibitor venlafaxine also an acceptable early option. Temporary co-administration of benzodiazepines can be considered. Maintenance treatment reduces relapse rates, but further research to determine optimal duration is needed. For patients not responding to first-line agents several pharmacotherapy options are available, but there is a notable paucity of data on the optimal choice. [PubMed Citation] [Order full text from Infotrieve]


9) Jhanjee A, Anand KS, Bajaj BK
Hypersexual features in Huntington's disease.
Singapore Med J. 2011 Jun;52(6):e131-3.
We report the case of a 30-year-old woman with a rare presentation of early adulthood Huntington's disease (HD) with hypersexuality. It is not known if sexual dysfunction in HD patients is due to a specific brain lesion or adverse psychosocial factors associated with HD. Although there are no evidence-based treatment guidelines for hypersexuality in HD, our patient exhibited significant improvement with olanzapine and haloperidol. [PubMed Citation] [Order full text from Infotrieve]


10) Wu LT
Substance abuse and rehabilitation: responding to the global burden of diseases attributable to substance abuse.
Subst Abuse Rehabil. 2010 Oct;2010(1):5-11.
Alcohol, tobacco, and illegal drug use are pervasive throughout the world. Substance use problems are among the major contributors to the global disease burden, which includes disability and mortality. The benefits of treatment far outweigh the economic costs. Despite the availability of treatment services, however, the vast majority of people with substance use disorders do not seek or use treatment. Barriers to and unmet need for evidence-based treatment are widespread even in the United States. Women, adolescents, and young adults are especially vulnerable to adverse effects from substance abuse, but they face additional barriers to getting evidence-based treatment or other social/medical services. Substance use behaviors and the diseases attributable to substance use problems are preventable and modifiable. Yet the ever-changing patterns of substance use and associated problems require combined research and policy-making efforts from all parts of the world to establish a viable knowledge base to inform for prevention, risk-reduction intervention, effective use of evidence-based treatment, and rehabilitation for long-term recovery. The new international, open-access, peer-reviewed Substance Abuse and Rehabilitation (SAR) journal strives to provide an effective platform for sharing ideas for solutions and disseminating research findings globally. Substance use behaviors and problems have no boundaries. The journal welcomes papers from all regions of the world that address any aspect of substance use, abuse/dependence, intervention, treatment, and policy. The "open-access" journal makes cutting edge knowledge freely available to practitioners and researchers worldwide, and this is particularly important for addressing the global disease burden attributable to substance abuse. [PubMed Citation] [Order full text from Infotrieve]


11) Winters KC, Botzet AM, Fahnhorst T
Advances in Adolescent Substance Abuse Treatment.
Curr Psychiatry Rep. 2011 Jun 24;
Alcohol and other drug use among adolescents has been a public health problem for decades. Although some substance use may be developmentally routine, a concerning number of adolescents meet criteria for a substance use disorder and could greatly benefit from a quality treatment experience. However, parents and health care providers want evidence of the efficacy of adolescent-specific treatment programs. This review summarizes four factors surrounding the efficacy of current adolescent treatment programs: 1) adolescent-specific treatment services; 2) the variety of therapeutic modalities; 3) relapse and recovery rates; and 4) the need for evidence-based, quality assessments and research. Current adolescent treatment efforts are summarized, and the recent literature regarding the efficacy of adolescent treatment and recovery rates is discussed. [PubMed Citation] [Order full text from Infotrieve]


12) Fulford KW
Neuroscience and Values: A Case Study Illustrating Developments in Policy, Training and Research in the UK and Internationally.
Mens Sana Monogr. 2011 Jan;9(1):79-92.
In the current climate of dramatic advances in the neurosciences, it has been widely assumed that the diagnosis of mental disorder is a matter exclusively for value-free science. Starting from a detailed case history, this paper describes how, to the contrary, values come into the diagnosis of mental disorders, directly through the criteria at the heart of psychiatry's most scientifically grounded classification, the American Psychiatric Association's DSM (Diagnostic and Statistical Manual). Various possible interpretations of the prominence of values in psychiatric diagnosis are outlined. Drawing on work in the Oxford analytic tradition of philosophy, it is shown that, properly understood, the prominence of psychiatric diagnostic values reflects the necessary engagement of psychiatry with the diversity of individual human values. This interpretation opens up psychiatric diagnostic assessment to the resources of a new skills-based approach to working with complex and conflicting values (also derived from analytic philosophy) called 'values-based practice.' Developments in values-based practice in training, policy and research in mental health are briefly outlined. The paper concludes with an indication of how the integration of values-based with evidence-based approaches provides the basis for psychiatric practice in the twenty-first century that is both science-based and person-centred. [PubMed Citation] [Order full text from Infotrieve]


13) Altınbaş K, Smith D, Oral ET
Adherence to Turkish psychiatric association guideline for bipolar depression treatment in a specialized mood disorders outpatient unit.
Psychiatr Danub. 2011 Jun;23(2):189-93.
[PubMed Citation] [Order full text from Infotrieve]


14) Williams RA, Gatien G, Hagerty B
Design-element alternatives for stress-management intervention websites.
Nurs Outlook. 2011 Jun 18;
Typical public and military-sponsored websites on stress and depression tend to be prescriptive. Some require users to complete lengthy questionnaires. Others reproduce printed flyers, papers, or educational materials not adapted for online use. Some websites require users to follow a prescribed path through the material. Stress Gym was developed as a first-level, evidence-based, website intervention to help U.S. military members learn how to manage mild to moderate stress and depressive symptoms using a self-help intervention with progress tracking and 24/7availablility. It was designed using web-based, health-management intervention design elements that have been proven effective and users reported they prefer. These included interactivity, self-pacing, and pleasing aesthetics. Users learned how to manage stress by accessing modules they choose, and by practicing proven stress management strategies interactively immediately after login. Test results of Stress Gym with Navy members demonstrated that it was effective, with significant decreases in reported perceived stress levels from baseline to follow-up assessment. Stress Gym used design elements that may serve as a model for future websites to emulate and improve upon, and as a template against which to compare and contrast the design and functionality of future online, health-intervention websites. [PubMed Citation] [Order full text from Infotrieve]


15) Kroken RA, Mellesdal LS, Wentzel-Larsen T, Jørgensen HA, Johnsen E
Time-dependent effect analysis of antipsychotic treatment in a naturalistic cohort study of patients with schizophrenia.
Eur Psychiatry. 2011 Jun 15;
OBJECTIVE: Evidence based treatment of schizophrenia as well as antipsychotic drug utility patterns have changed considerably in recent years and the present study aims to investigate the current level of unplanned hospital readmissions in a cohort of patients with schizophrenia, and to determine the risk-reducing effects of current antipsychotic drug treatment. METHOD: An open cohort study included all consecutively discharged patients with schizophrenia in a 3-year period (n=277). The treatment-dependent variables were entered in a multivariate Cox survival analyses with time to unplanned readmission as the dependent variable. RESULTS: 11.2% of patients were readmitted within 30days of discharge, and 44.8% were readmitted within 12months. Antipsychotic monotherapy reduced the risk of readmission by 74.9%. Treatment in CMHC also had a risk-reducing effect. The prescription rate of clozapine in this sample was 10.1%. DISCUSSION: The over-all level of unplanned readmissions was in correspondence with the findings of others. Current antipsychotic drug treatment independently offers strong protection against unplanned readmissions. There may be a potential for further optimalizing antipsychotic drug treatment according to treatment guidelines. CONCLUSIONS: Unplanned readmissions are very common for patients with schizophrenia but antipsychotic drug treatment is associated with a strong risk-reducing effect in this regard. [PubMed Citation] [Order full text from Infotrieve]


16) Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, Bienfait KL, Friedman J
Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial.
Am J Psychiatry. 2011 Jun 15;
Objective: Despite the negative effects of depression in Parkinson's disease, there is currently no evidence-based standard of care. The purpose of this study was to examine the efficacy of individually administered cognitive-behavioral therapy (CBT), relative to clinical monitoring (with no new treatment), for depression in this medical population. Method: Eighty depressed (based on DSM-IV criteria) patients with Parkinson's disease participated in a randomized, controlled trial of CBT relative to clinical monitoring (1:1 ratio) in an academic medical center from April 2007 to July 2010. All patients continued to maintain stable medication regimens under the care of their personal physicians. The 17-item Hamilton Depression Rating Scale (HAM-D) total score was the primary outcome. CBT was modified to meet the unique needs of the Parkinson's disease population and provided for 10 weeks. Assessments were completed by blind raters at baseline and 5 (midpoint), 10 (end of treatment), and 14 weeks (follow-up evaluation) postrandomization. Results: The CBT group reported greater reductions in depression (change in HAM-D score) than the clinical monitoring group. At week 10, the mean HAM-D score change was 7.35 for CBT relative to 0.05 for clinical monitoring. CBT was also superior to clinical monitoring on several secondary outcomes (i.e., Beck Depression Inventory scores, anxiety, quality of life, coping, Parkinson's disease symptom ratings). There were more treatment responders in the CBT group than the clinical monitoring group (56% versus 8%, respectively). Conclusions: CBT may be a viable approach for the treatment of depression in Parkinson's disease. Further research is needed to replicate and extend these findings. [PubMed Citation] [Order full text from Infotrieve]


17) Visscher PM, Goddard ME, Derks EM, Wray NR
Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses.
Mol Psychiatry. 2011 Jun 14;
In this article, we review some of the data that contribute to our understanding of the genetic architecture of psychiatric disorders. These include results from evolutionary modelling (hence no data), the observed recurrence risk to relatives and data from molecular markers. We briefly discuss the common-disease common-variant hypothesis, the success (or otherwise) of genome-wide association studies, the evidence for polygenic variance and the likely success of exome and whole-genome sequencing studies. We conclude that the perceived dichotomy between 'common' and 'rare' variants is not only false, but unhelpful in making progress towards increasing our understanding of the genetic basis of psychiatric disorders. Strong evidence has been accumulated that is consistent with the contribution of many genes to risk of disease, across a wide range of allele frequencies and with a substantial proportion of genetic variation in the population in linkage disequilibrium with single-nucleotide polymorphisms (SNPs) on commercial genotyping arrays. At the same time, most causal variants that segregate in the population are likely to be rare and in total these variants also explain a significant proportion of genetic variation. It is the combination of allele frequency, effect size and functional characteristics that will determine the success of new experimental paradigms such as whole exome/genome sequencing to detect such loci. Empirical results suggest that roughly half the genetic variance is tagged by SNPs on commercial genome-wide chips, but that individual causal variants have a small effect size, on average. We conclude that larger experimental sample sizes are essential to further our understanding of the biology underlying psychiatric disorders.Molecular Psychiatry advance online publication, 14 June 2011; doi:10.1038/mp.2011.65. [PubMed Citation] [Order full text from Infotrieve]


18) Anagnostopoulos DC, Soumaki E
Perspectives of intellectual disability in Greece: epidemiology, policy, services for children and adults.
Curr Opin Psychiatry. 2011 Jun 10;
PURPOSE OF REVIEW: The purpose of this review is to investigate the existing situation regarding how people with intellectual disability are treated in contemporary Greece. RECENT FINDINGS: The legal rights of people with intellectual disability are fully protected. Steady improvement of special education, along with development of educational services. Greater access of people with intellectual disability is being developed. There is, however, a lack of specialized health services. A relatively adequate social and financial support of families of individuals with severe intellectual disability. There is very limited access to employment for people with intellectual disability. Lack of rigorous research and representative studies on intellectual disability and insufficient epidemiological data. SUMMARY: The main conclusion of this review is that, since 1980, the situation of people with intellectual disability has been steadily improving in the areas of civil rights, social support, special education, and use of health services. However, the deficiency of official national data on intellectual disability does not allow a complete and documented evaluation of the situation in the country. Furthermore, the lack of epidemiological data undermines the development and establishment of evidence-based public policies. [PubMed Citation] [Order full text from Infotrieve]


19) Sorensen JL, Kosten T
Developing the tools of implementation science in substance use disorders treatment: Applications of the consolidated framework for implementation research.
Psychol Addict Behav. 2011 Jun;25(2):262-8.
The implementation of evidence-based treatments (EBTs) and practices (EBPs) depends on both top-down and bottom-up responsibilities. Many articles in this special section on Implementation Science in Substance Use Disorders address the interaction between these two approaches when implementing new substance use disorder (SUD) treatments. Generally the articles place this interaction within the Consolidated Framework for Implementation Research (CFIR), a relatively new and comprehensive synthesis of theories and conceptualizations of the components needed for successful implementation strategies. The range of SUD treatments covered includes well-established behavioral interventions, such as screening and brief interventions for alcohol, as well as new pharmacotherapies, such as buprenorphine for opiates. One contribution uses the CFIR to review continuing care interventions and self-help groups that can follow-up after more intensive clinical care. External and internal pressures for change drive implementation. The successful EBT/EBP implementations reviewed in these articles recognized these potential change drivers in designing their strategy for introducing the EBT/EBP, and they modified aspects of the EBT/EBP to satisfy many of these drivers. The CFIR model has limitations, as do the contributions to this special section. The implementation science field is new and developing rapidly, and many of the EBTs and EBPs were developed and tested through controlled studies evaluating the efficacy of interventions under controlled conditions, rather than examining their performance in the broader landscape of addiction treatment programs. These limitations may also be considered as boundary conditions to be explored in further research, implementation, and development of the next edition of the CFIR. (PsycINFO Database Record (c) 2011 APA, all rights reserved). [PubMed Citation] [Order full text from Infotrieve]


20) Prado Cortez FC, Boer DP, Baltieri DA
A Psychosocial Study of Male-to-Female Transgendered and Male Hustler Sex Workers in São Paulo, Brazil.
Arch Sex Behav. 2011 Jun 11;
This study examined sociodemographic variables, personality characteristics, and alcohol and drug misuse among male sex workers in the city of Santo André, São Paulo, Brazil. A total of 45 male-to-female transgender sex workers and 41 male hustlers were evaluated in face-to-face interviews at their place of work from 2008 to 2010. A "snowball" sampling procedure was used to access this hard-to-reach population. Male-to-female transgender sex workers reported fewer conventional job opportunities, fewer school problems, and higher harm avoidance and depression levels than male hustlers. Also, transgender sex workers reported earning more money through sex work and more frequently living in hostels with peers than their counterparts. As biological male sex workers are a heterogeneous population, attempts to classify them into distinctive groups should be further carried out as a way to better understand and identify their behavior, design effective health interventions, and consequently minimize the likelihood of unintended adverse outcomes. Our study showed that gender performance can be an important variable to be considered by researchers and policy makers when working with sex workers and developing HIV/AIDS prevention and public health programs, given that transgender and male sex workers not only display distinctive behavior and physical appearance but also reveal differences on specific psychological measures, such as personality traits and depression levels. We recommend that counselors working with this population strike a balance between facilitating self-disclosure and establishing more evidence-based directive interventions. [PubMed Citation] [Order full text from Infotrieve]